A Chinese study suggested that cold weather may make people more susceptible to compared with myocardial infarction from obstructive disease. (European Heart Journal)
Pneumonia and urinary tract infection of acute myocardial infarction, according to a Danish cohort study. (European Journal of Preventive Cardiology)
People with bipolar disorder and schizophrenia had outsized risks of , another Danish study showed. (Heart)
For patients with systolic heart failure and moderate aortic stenosis, (TAVR) did not improve clinical outcomes over standard therapy in a small randomized trial. (Journal of the American College of Cardiology)
Early aortic valve intervention also failed to show clinical benefit in those with in a separate trial. (JAMA)
Cardiawave said its device met expectations for 6-month results in a pivotal trial of severe symptomatic calcific aortic stenosis.
A reduced the need for pharmacological circulatory support while maintaining hemodynamic stability in patients with ST-elevation myocardial infarction-induced cardiogenic shock, per a DanGer Shock substudy. (JAMA Cardiology)
Medtronic announced FDA approval of its for radiofrequency and pulsed field ablation in persistent atrial fibrillation.
The , which predicts post-percutaneous coronary intervention bleeding, offered a slight improvement in discrimination over existing scores. (Circulation)
Routine upfront use of for severely (but not extremely) calcified lesions did not improve stent expansion or patient outcomes compared with routine balloon angioplasty prior to stenting, according to ECLIPSE trial results highlighted by Mount Sinai.
In a head-to-head comparison of two-stent strategies for coronary bifurcation lesions outside the left main, the came out on top. (Circulation: Cardiovascular Interventions)
The sutureless, fully absorbable performed well for large-bore vessel punctures in the PATCH IDE pivotal study, the device maker announced.
, reflecting cultural pressures to convey masculinity, in young men was associated with fewer hypertension and diabetes diagnoses and treatment in adulthood, a cohort study suggested. (JAMA Network Open)
Two years after radiofrequency renal denervation with the , patients continued to show significant blood pressure reductions in the SPYRAL HTN-ON MED study, Medtronic said.
A first-in-human study supported an investigational cerebroprotection agent -- a -- for phase II study in stroke and traumatic brain injury. (Stroke)